S

Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281

Watchlist Manager
Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
Watchlist
Price: 30.72 CNY -3.27% Market Closed
Market Cap: 2.2B CNY

Relative Value

The Relative Value of one Shandong Keyuan Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 30.72 CNY, Shandong Keyuan Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Shandong Keyuan Pharmaceutical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
37
vs Industry
26
Median 3Y
4.9
Median 5Y
4.9
Industry
2.7
Forward
4.6
vs History
14
vs Industry
12
Median 3Y
36.9
Median 5Y
36.9
Industry
21.6
Forward
30.9
vs History
vs Industry
8
Median 3Y
-35.3
Median 5Y
-35.3
Industry
16.9
vs History
vs Industry
Median 3Y
-13.9
Median 5Y
-13.9
Industry
22.9
vs History
42
vs Industry
45
Median 3Y
1.6
Median 5Y
1.6
Industry
2.3
vs History
28
vs Industry
32
Median 3Y
4.1
Median 5Y
4.1
Industry
3
Forward
4.1
vs History
48
vs Industry
23
Median 3Y
8.7
Median 5Y
8.7
Industry
5.6
vs History
11
vs Industry
9
Median 3Y
36.2
Median 5Y
36.2
Industry
13.4
vs History
11
vs Industry
11
Median 3Y
36.2
Median 5Y
36.2
Industry
16.7
vs History
vs Industry
10
Median 3Y
-30.5
Median 5Y
-30.5
Industry
16.1
vs History
vs Industry
Median 3Y
-8.3
Median 5Y
-8.3
Industry
18.9
vs History
60
vs Industry
37
Median 3Y
1.8
Median 5Y
1.8
Industry
2

Multiples Across Competitors

Competitors Multiples
Shandong Keyuan Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
2.2B CNY 5 42 50 50
US
Eli Lilly and Co
NYSE:LLY
977B USD 16.4 53.1 35.6 38.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
528.3B USD 5.7 21 17.2 22.3
CH
Roche Holding AG
SIX:ROG
276.8B CHF 4.5 29.3 12.5 14.5
UK
AstraZeneca PLC
LSE:AZN
218.6B GBP 5 31.2 108.4 158.7
CH
Novartis AG
SIX:NOVN
221.9B CHF 4.9 19.2 12.1 15.7
US
Merck & Co Inc
NYSE:MRK
276B USD 4.3 14.5 10.3 12.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.3 16.1 11.2 13
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
147.2B USD 2.3 15 7.6 10.4
P/E Multiple
Earnings Growth PEG
CN
S
Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
Average P/E: 26.8
42
11%
3.8
US
Eli Lilly and Co
NYSE:LLY
53.1
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
21
29%
0.7
CH
Roche Holding AG
SIX:ROG
29.3
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.2
37%
0.8
CH
Novartis AG
SIX:NOVN
19.2
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.5
15%
1
DK
Novo Nordisk A/S
CSE:NOVO B
16.1
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
15
27%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
S
Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
Average EV/EBITDA: 404.5
50
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.6
34%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
17.2
9%
1.9
CH
Roche Holding AG
SIX:ROG
12.5
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
12.1
6%
2
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
11.2
1%
11.2
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
S
Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
Average EV/EBIT: 1 716.9
50
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.2
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
22.3
15%
1.5
CH
Roche Holding AG
SIX:ROG
14.5
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
158.7
23%
6.9
CH
Novartis AG
SIX:NOVN
15.7
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
13
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
7%
1.5